Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
All content for Can We End Epidemics? is the property of Foreign Policy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
The global economy is in a state of uncertainty as governments around the world cut budgets and introduce belt-tightening austerity measures. Progress is more urgent now than ever for people living with and affected by infectious diseases. Fully funding innovative options to test, prevent, and treat infectious diseases, as well as research and development exploring cures, is critical. In this episode, host Henry Bonsu brings together Peter Sands, the executive director of the Global Fund, Ricardo Baptista Leite, a former member of Portugal’s parliament and CEO for HealthAI — The Global Agency for Responsible AI in Health, and Helen McDowell, the head of government affairs and global public health at ViiV Healthcare, to ask how national health systems and the international community might provide dependable, long-term funding to end infectious disease epidemics.
Glossary of terms used this season: https://foreignpolicy.com/podcasts/can-we-end-epidemics/
Can We End Epidemics?
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
